Cigarette smoke and concomitant smoke‐induced inflammation can induce the production and release of TGF‐β1,11 suggesting that TGF‐β1 is a potential therapeutic target for COPD treatment. This evidence concerns the gene TGFB1 and chronic obstructive pulmonary disease.